Stock CTCX CARMELL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Carmell Corporation

Equities

CTCX

US1429221039

Market Closed - Nasdaq
Other stock markets
 21:30:00 12/06/2024 BST 		5-day change 1st Jan Change
2.09 USD -6.49% Intraday chart for Carmell Corporation -19.62% -45.14%
05-15 Carmell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-11 Carmell Corporation announced that it has received $3 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Carmell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Carmell Announces Successful Closing of $3.0 Million Private Placement
AQ
Carmell Corporation announced that it has received $3 million in funding
CI
Carmell Announces $3.0 Million Private Placement
AQ
Carmell Corporation announced that it expects to receive $3 million in funding
CI
Carmell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
AQ
An undisclosed buyer completed the acquisition of Axolotl Biologix, Inc. from Carmell Corporation.
CI
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Fed Maintains Rate Cut Outlook
MT
Carmell Sells Axolotl Biologix Unit -- Shares Jump Premarket
MT
An undisclosed buyer entered into a a definitive agreement to acquire Axolotl Biologix, Inc. from Carmell Corporation ).
CI
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
CI
Carmell Corporation Announces Appointment of Dr. Bradley Calobrace to Scientific Advisory Board
CI
Carmell Corp Announces Appointment of Dr. Jason D. Bloom to Scientific Advisory Board
CI
Carmell Corporation Announces Appointment of Dr. Adam Rubinstein to Scientific Advisory Board
CI
Carmell Corporation Announces Appointment of Dr. Gregory A. Buford to Scientific Advisory Board
CI
Carmell Corporation Announces Appointment of Dr. Sean Kelishadi to Scientific Advisory Board
CI
Carmell Corporation Announces Addition of Two Independent Directors
CI
Carmell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Carmell Therapeutics Corporation(NasdaqCM:CTCX) added to S&P TMI Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTCX Stock
  4. News Carmell Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW